(VIANEWS) – Kimball Electronics (KE), Texas Capital Bancshares (TCBI), The Bank of Princeton (BPRN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Kimball Electronics (KE)
25.2% sales growth and 9.46% return on equity
Kimball Electronics, Inc. provides contract electronics manufacturing services and diversified manufacturing services to customers in the automotive, medical, industrial, and public safety end markets. The company's manufacturing services include design services and support, supply chain services and support, and rapid prototyping and product introduction support services, as well as product design, and process validation and qualification services. Its manufacturing services also comprise industrialization and automation of manufacturing processes; reliability testing, including testing of products under a series of environmental conditions; production and testing of printed circuit board assemblies; assembly, production, and packaging of medical disposables and other non-electronic products; design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics; software design services; and product life cycle management services. The company has operations in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Kimball Electronics, Inc. was founded in 1961 and is headquartered in Jasper, Indiana.
Earnings Per Share
As for profitability, Kimball Electronics has a trailing twelve months EPS of $1.79.
PE Ratio
Kimball Electronics has a trailing twelve months price to earnings ratio of 13.37. Meaning, the purchaser of the share is investing $13.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.46%.
Sales Growth
Kimball Electronics’s sales growth is 23% for the present quarter and 25.2% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kimball Electronics’s EBITDA is 29.38.
2. Texas Capital Bancshares (TCBI)
18.6% sales growth and 10.61% return on equity
Texas Capital Bancshares, Inc. operates as the bank holding company for Texas Capital Bank, National Association that provides various banking products and services for commercial businesses, and professionals and entrepreneurs. It offers business deposit products and services, including commercial checking accounts, lockbox accounts, and cash concentration accounts, as well as other treasury management services, including information services, wire transfer initiation, ACH initiation, account transfer, and service integration; and consumer deposit products, such as checking accounts, savings accounts, money market accounts, and certificates of deposit. The company also provides commercial loans for general corporate purposes comprising financing for working capital, internal growth, and acquisitions, as well as financing for business insurance premiums; real estate term and construction loans; mortgage warehouse lending; mortgage correspondent aggregation; equipment finance and leasing; treasury management services, including online banking and debit and credit card services; escrow services; and letters of credit. In addition, it offers personal wealth management and trust services; secured and unsecured loans; and online and mobile banking services. Further, the company provides American Airlines AAdvantage, an all-digital branch offering depositors. It operates in Austin, Fort Worth, Dallas, Houston, and San Antonio metropolitan areas of Texas. Texas Capital Bancshares, Inc. was founded in 1996 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Texas Capital Bancshares has a trailing twelve months EPS of $6.22.
PE Ratio
Texas Capital Bancshares has a trailing twelve months price to earnings ratio of 7.75. Meaning, the purchaser of the share is investing $7.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.61%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 108.6%, now sitting on 1.16B for the twelve trailing months.
Yearly Top and Bottom Value
Texas Capital Bancshares’s stock is valued at $48.22 at 01:22 EST, way below its 52-week high of $69.27 and higher than its 52-week low of $45.81.
Sales Growth
Texas Capital Bancshares’s sales growth is 30.6% for the present quarter and 18.6% for the next.
3. The Bank of Princeton (BPRN)
16.7% sales growth and 12.15% return on equity
The Bank of Princeton provides various banking products and services. The company accepts checking, savings, attorney trust, and money market accounts, as well as certificates of deposit. Its loan products include commercial real estate and multi-family, commercial and industrial, construction, residential first-lien mortgage, home equity, and consumer loans, as well as lines of credit. The company also provides debit and credit cards; and money orders, direct deposit, automated teller machines, cashier's checks, safe deposit boxes, wire transfers, night depository, remote deposit capture, savings bonds redemption, bank-by-mail, online and automated telephone banking, Internet banking, payroll-related services, and merchant credit card processing services. It operates 21 branches in Princeton, including parts of Mercer, Somerset, Hunterdon, Monmouth, Middlesex, Ocean, Gloucester, Camden, and Burlington counties in New Jersey, and additional areas in portions of Philadelphia, Montgomery, and Bucks counties in Pennsylvania. The Bank of Princeton was founded in 2007 and is headquartered in Princeton, New Jersey.
Earnings Per Share
As for profitability, The Bank of Princeton has a trailing twelve months EPS of $4.13.
PE Ratio
The Bank of Princeton has a trailing twelve months price to earnings ratio of 7.67. Meaning, the purchaser of the share is investing $7.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.15%.
Moving Average
The Bank of Princeton’s value is below its 50-day moving average of $33.81 and above its 200-day moving average of $30.92.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 1.1% and a drop 60.2% for the next.
Volume
Today’s last reported volume for The Bank of Princeton is 4018 which is 55.61% below its average volume of 9053.
4. Huron Consulting Group (HURN)
9.9% sales growth and 13.44% return on equity
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. Its Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. The company's Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. Its Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Huron Consulting Group has a trailing twelve months EPS of $3.67.
PE Ratio
Huron Consulting Group has a trailing twelve months price to earnings ratio of 22.04. Meaning, the purchaser of the share is investing $22.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.44%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 34.7% and 20.5%, respectively.
Volume
Today’s last reported volume for Huron Consulting Group is 127762 which is 10.98% below its average volume of 143521.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Huron Consulting Group’s EBITDA is 49.36.
Sales Growth
Huron Consulting Group’s sales growth is 15.2% for the current quarter and 9.9% for the next.
5. Semler Scientific (SMLR)
9.2% sales growth and 28.3% return on equity
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, Semler Scientific has a trailing twelve months EPS of $2.01.
PE Ratio
Semler Scientific has a trailing twelve months price to earnings ratio of 11.56. Meaning, the purchaser of the share is investing $11.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.3%.
Yearly Top and Bottom Value
Semler Scientific’s stock is valued at $23.24 at 01:22 EST, way under its 52-week high of $50.30 and way above its 52-week low of $19.12.
Sales Growth
Semler Scientific’s sales growth is 13.5% for the current quarter and 9.2% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 55.6% and 19.5%, respectively.
6. Flowers Foods (FLO)
8.3% sales growth and 16% return on equity
Flowers Foods, Inc. produces and markets packaged bakery products in the United States. It offers fresh breads, buns, rolls, snack cakes, and tortillas, as well as frozen breads and rolls under the Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, Mrs. Freshley's, and Tastykake brand names. The company distributes its products through a direct-store-delivery distribution and a warehouse delivery system, as well as operates 46 bakeries comprising 44 owned and two leased. Its customers include mass merchandisers, supermarkets and other retailers, convenience stores, national and regional restaurants, quick-serve chains, retail in-store bakeries, foodservice distributors, food wholesalers, institutions, dollar stores, and vending companies. The company was formerly known as Flowers Industries and changed its name to Flowers Foods, Inc. in 2001. Flowers Foods, Inc. was founded in 1919 and is headquartered in Thomasville, Georgia.
Earnings Per Share
As for profitability, Flowers Foods has a trailing twelve months EPS of $1.07.
PE Ratio
Flowers Foods has a trailing twelve months price to earnings ratio of 25.11. Meaning, the purchaser of the share is investing $25.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16%.
Volume
Today’s last reported volume for Flowers Foods is 1121730 which is 50.31% below its average volume of 2257700.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 1, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 3.24%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 13.6% and a negative 3.2%, respectively.
7. Charles River Laboratories (CRL)
7.3% sales growth and 17.26% return on equity
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Earnings Per Share
As for profitability, Charles River Laboratories has a trailing twelve months EPS of $9.68.
PE Ratio
Charles River Laboratories has a trailing twelve months price to earnings ratio of 21.03. Meaning, the purchaser of the share is investing $21.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.26%.
Moving Average
Charles River Laboratories’s worth is way below its 50-day moving average of $229.50 and below its 200-day moving average of $220.52.
8. Ritchie Bros. Auctioneers Incorporated (RBA)
5.8% sales growth and 26.5% return on equity
Ritchie Bros. Auctioneers Incorporated, an asset management and disposition company, sells industrial equipment and other durable assets through its unreserved auctions, online marketplaces, listing services, and private brokerage services. It sells a range of used and unused commercial assets, including earthmoving equipment, truck tractors and trailers, government surplus, oil and gas equipment, and other industrial assets, as well as construction and heavy machinery. The company also offers live auction events with online bidding. It sells used equipment to its customers through live unreserved auctions at 40 auction sites worldwide. The company serves construction, transportation, agriculture, energy, oil and gas, mining, and forestry sectors. It operates in the United States, Canada, Australia, the United Arab Emirates, the Netherlands, Europe, the Middle East, Asia, and internationally. Ritchie Bros. Auctioneers Incorporated was founded in 1958 and is headquartered in Burnaby, Canada.
Earnings Per Share
As for profitability, Ritchie Bros. Auctioneers Incorporated has a trailing twelve months EPS of $1.54.
PE Ratio
Ritchie Bros. Auctioneers Incorporated has a trailing twelve months price to earnings ratio of 35.95. Meaning, the purchaser of the share is investing $35.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.5%.
Volume
Today’s last reported volume for Ritchie Bros. Auctioneers Incorporated is 1393860 which is 55.45% below its average volume of 3129420.
